New Triclazone 40 Tablet

Manufactured bySUN PHARMA LABORATORIES LTD
ContainsMetformin (500 mg) + Gliclazide (40 mg) + Pioglitazone (15 mg)
OFFER
Get 25% OFF!
Valid on prescription medicines, only for first time user
PRACTO
PRACTO
COPY CODE
Description

New Triclazone 40 Tablet is a combination medicine used as a third-line treatment for type II diabetes mellitus when diet, exercise, single agents, and second-line therapy with two drugs do not result in adequate blood glucose control. This medicine is not recommended for use in patients less than 18 years of age.

Substitutes

List of substitutes for New Triclazone 40 Tablet

Side effects

Major & minor side effects for New Triclazone 40 Tablet

  • Dizziness
  • Nausea or vomiting
  • Diarrhea
  • Confusion
  • Weakness
  • Changes in vision
  • Decreased heartbeat
  • Abdominal pain
  • Constipation
  • Skin rash
  • Elevated liver enzymes
  • Sweating

Uses of New Triclazone 40 Tablet

What is it prescribed for?

  • Type II Diabetes Mellitus
Read More
Concerns

Commonly asked questions

  • Onset of action
    The effect of this medicine can be observed within 1 to 3 hours of administration of the dose.
  • Duration of effect
    The effect of this medicine lasts for an average duration of 24 hours.
  • Safe with alcohol?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
  • Is it habit forming?
    No habit forming tendency has been reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to pioglitazone, gliclazide, any other sulfonylureas, metformin, any other biguanides, or any other inactive ingredients present along with these medicines.

Diabetic ketoacidosis

This medicine is not recommended for use in patients suffering from diabetic ketoacidosis due to the increased risk of worsening of the patient's condition.

Heart Failure

This medicine is not recommended for use in patients with a history of heart failure since it may worsen the patient's condition.

Severe kidney impairment

This medicine is not recommended for use in patients with a severe impairment of kidney function due to the increased risk of serious adverse effects.

Metabolic Acidosis

This medicine is not recommended for use in patients with metabolic acidosis since it may worsen the patient's condition.

Severe Hepatic impairment

This medicine is not recommended for use in patients with a known history of severe liver impairment due to the increased risk of serious adverse effects.

Type 1 Diabetes mellitus

This medicine is not recommended for use in patients with type I diabetes mellitus since it is not effective in treating such patients.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Hypoglycemia

This medicine should be administered with caution in patients prone to having hypoglycemic episodes due to the increased risk of serious adverse effects. Close monitoring of blood glucose levels is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Impaired kidney function

This medicine should be used with extreme caution in patients with an impaired kidney function due to an increase in the risk of kidney injuries and serious adverse effects. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Impaired liver function

This medicine should be used with caution in patients with an impaired liver function due to an increase in the risk of worsening of the patient's condition. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Edema

This medicine should be used with caution in patients with edema due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Ovulation problems

This medicine should be used with caution in premenopausal patients due to the increase in chances of ovulation. Adequate contraceptive measures are recommended for such patients to avoid an unplanned pregnancy.

Bone fractures

This medicine may increase the risk of fractures in some patients. This risk is especially higher in female patients. Close monitoring of bone health is recommended during treatment with this medicine. Replacement with a suitable alternative may be required based on the clinical condition.

Pediatric use

This medicine is not recommended for use in children and adolescents since the safety and efficacy of use are not clinically established.

Stress

Use of this medicine should be discontinued in patients exposed to stressful conditions such as a fever, trauma, surgeries, or accidents since it may not be effective in controlling blood sugar levels in these conditions. Replacement with a suitable alternative should be considered under your doctor's supervision.

Diarrhea

This medicine may cause diarrhea when therapy is initiated. In most cases, diarrhea subsides by itself. Contact your doctor if the problem persists for longer durations. Therapy may need to be discontinued in some cases based on the clinical condition.

Lactic Acidosis

This medicine may cause lactic acidosis, which may be fatal, in some patients. This risk is especially higher in patients suffering from heart diseases, kidney diseases, etc. Report any unusual symptoms to the doctor immediately. Replacement with a suitable alternative may be required based on the clinical condition.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Interaction with Medicine

Amlodipine

Estradiol

Gatifloxacin

Azole antifungal agents

Gemfibrozil

Iodinated Contrast Media

Aloe Vera

Insulin injection

Phenylbutazone

Chlorpromazine

Glucocorticoids

Disease interactions

Hemolytic Anemia/G6PD Deficiency

This medicine is not recommended for use in patients with Hemolytic Anemia or G6PD deficiency due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Cardiovascular disease

This medicine is not recommended for use in patients with a known history of cardiovascular diseases due to the increased risk of serious adverse effects such as fluid retention. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Bladder cancer

This medicine is not recommended for use in patients with an active bladder cancer due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative should be considered under your doctor's supervision.

Liver Disease

This medicine should be used with extreme caution in patients with a known history of liver impairment due to the increased risk of severe adverse effects. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Anemia

This medicine is not recommended for use in patients suffering from anemia since it may worsen the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Vitamin B12 deficiency

This medicine should be used with extreme caution in patients with vitamin B12 deficiency since it may worsen the patient's condition. Appropriate vitamin B12 supplementation and dose adjustments may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine as prescribed by the doctor. It is advised to take this medicine with meals. Your dose is likely to change over time based on the therapeutic response and clinical condition. Regular monitoring of blood sugar levels is recommended during treatment with this medicine. You should always carry a sugar candy with you to counteract unexpected lowering of blood sugar levels. Do not change the dose or duration of use without consulting your doctor. This medicine will show better results if you maintain a strict exercise and diet regimen. Consult the doctor if you experience any undesirable side effects.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

May cause sleepiness

How it works
Metformin decreases absorption of glucose from the intestines and increases the action of insulin in the body. Gliclazide works by increasing the release of insulin from the pancreas. Pioglitazone decreases insulin resistance without causing any strain on the pancreas and reduces the production of glucose from the liver. Their combination is thus better effective than monotherapy and second-line therapy in lowering the blood glucose levels.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Antidiabetic combinations

Schedule

Schedule H

DailyMed - Pioglitazone hydrochloride tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 16 March 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f2d7000-37ca-4e09-98ec-07d1c0354cb3

Pioglitazone: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 16 March 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a699016.html

Gliclazide - DrugBank [Internet]. Drugbank.ca. 2017 [cited 21 March 2017]. Available from:

https://www.drugbank.ca/drugs/DB01120

DailyMed - Metformin hcl tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 1 March 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d98aea3-35ba-447a-b88f-a5a20b612b2f

[Internet]. 2017 [cited 18 October 2017]. Available from:

https://www.medicines.org.uk/emc/PIL.26348.latest.pdf
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Book a doctor

Chat with verified doctors starting @ ₹99
Book now
Something doesn’t feel right?
Report an error